ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Charles SLBG Foundation and First Derm Complete Successful Skin Cancer Screening Campaign

By: Get News

The Charles SLBG Foundation, in partnership with First Derm, has concluded a highly impactful 30-month campaign aimed at raising awareness and promoting early detection of skin cancer. Running from February 2022 to August 2024, this free skin cancer screening initiative provided more than 3,000 UK-based individuals with access to online dermatologists via the First Derm platform.

Through this project, 43 cases of possible melanoma were detected early, potentially saving lives and avoiding healthcare costs totaling £205,400. Early detection is crucial in reducing skin cancer fatalities, and the success of this campaign underscores the importance of accessible and timely dermatologist consultations.

The Charles SLBG Foundation was founded in memory of Charles, who lost his life to stage 4 metastatic melanoma in 2011. The foundation is dedicated to raising skin cancer awareness and preventing premature deaths through early diagnosis and treatment. With First Derm's platform, users could upload images of skin concerns and receive an online dermatologist evaluation within 24 hours. The majority of users were males between the ages of 20 and 29, underscoring the importance of reaching younger generations in the fight against skin cancer.

The £50,000 raised by the charity Charles SLBG Foundation covered consultation and advertising costs, making the service accessible to thousands at no cost.

This collaboration between the Charles SLBG Foundation and First Derm demonstrates the effectiveness of early detection in saving lives and reducing healthcare costs. The campaign is a testament to the foundation’s commitment to creating a future free of skin cancer deaths. Read the full report here

First Derm is a clinical research backed teledermatology service and has been operational globally since 2014. Anonymously check any skin concern and get an answer within hours by a board certified dermatologist. It will give you peace of mind, on the move, or from the comfort of your own home.

Media Contact
Company Name: Pressat
Contact Person: Alison Lancaster
Email: Send Email
Country: United Kingdom
Website: https://pressat.co.uk/



Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.